Google Übersetzer
Actinogen Medical Ltd
About
Actinogen Medical Ltd (AU:ACW) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 1 2026
Actinogen commences open-label phase of XanaMIA Alzheimer’s trial and provides business update
Apr 1 2026
ACW XanaMIA Alzheimers open label trial commences
Feb 27 2026
ACW successfully completes $16.8m Placement and SPP
Feb 26 2026
ACW HY26 results - XanaMIA pivotal Alzheimers trial progress
Feb 26 2026
Actinogen HY2025 financial report and Appendix 4D
Financials
Revenue
A$7.36 M
Market Cap
A$132.89 M
EPS
-0.01